According to the new market research report “Western Blotting Market by Product, (Consumables (Antibody), Instrument (Electrophoresis, Blotting System, Imager (Fluorescent))), Application (Biomedical, Clinical Diagnostics), End User (Research Institute, Hospital, Biopharma) – Global Forecast to 2026″, published by MarketsandMarkets™, the global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period.
Browse in-depth TOC on “Western blotting market”
312 – Tables
38 – Figures
275 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711
Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.
Covid-19 Impact on the Global Western Blotting Market
The COVID-19 outbreak has boosted research activity due to efforts to understand the dynamics of the infection. Because of the pandemic, companies have scaled up their operations for testing and tracking the infection. This provides a chance for growth in profits for companies operating in the NGS and PCR markets. The shift in demand for COVID-19, neurobiology, and oncology research has created a huge scope for testing solutions, such as western blotting, flow cytometry, ELISA, and drugs for researchers and laboratories.
By product segment, the consumables segment accounted for the largest share of the western blotting market in 2020.
Based on products, the western blotting market is segmented into instruments and consumables. In 2020, consumables commanded the major share of the western blotting products market. The large share of this product segment can primarily be attributed to the repeated use of consumables in the western blotting process and the use of reagents in large volumes.
By end user, the academic & research institutes segment accounted for the largest share of the western blotting market in 2020.
Based on end users, the western blotting market is segmented into academic & research institutes, biopharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, and other end users Academic & research institutes accounted for the largest share of the western blotting market in 2020. The large share of the academic & research institutes end-user segment can be attributed to growing government investments for research activities and increasing research in the area of proteomics.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235810711
North America accounted for the largest share of the western blotting market in 2020.
In 2020, North America accounted for the largest share of the western blotting market. The major factors driving the growth of this regional market include the presence of top manufacturers of western blotting products in this region, rise in research funding, increasing investments in proteomics research, and growing focus on personalized medicine.
The western blotting market is dominated by a few globally established players such as Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Techne Corporation (US), and Merck KGaA (Germany) are the prominent players operating in the western blotting market.
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Browse Related Reports:
Electrophoresis Reagents Market by Product (Dyes (EtBr & SYBR) Gels (Polyacrylamide, Starch, & Agarose) Buffer (TBE & TAE)) by Application (Protein Analysis, DNA & RNA Analysis) by Technique (Gel & Capillary Electrophoresis) – Global Forecast to 2020.
Immunoassay Market by Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), Application (Infectious Disease, Endocrinology, Cardiology, Oncology, Hematology), & End User – Global Forecast to 2019.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/healthcare-outsourcing-bpo-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/healthcare-bpo.asp